Matt Vanderhoek, Ph.D.
|2011||University of Wisconsin, Madison, Madison, WI|
Area:Medical Biophysics, Radiology
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Vanderhoek M, Perlman SB, Jeraj R. (2013) Impact of different standardized uptake value measures on PET-based quantification of treatment response. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1188-94|
|Vanderhoek M, Perlman SB, Jeraj R. (2012) Impact of the definition of peak standardized uptake value on quantification of treatment response. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 4-11|
|Liu G, Jeraj R, Vanderhoek M, et al. (2011) Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7634-44|
|Vanderhoek M, Juckett MB, Perlman SB, et al. (2011) Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging. Leukemia Research. 35: 310-6|
|Lawrence J, Vanderhoek M, Barbee D, et al. (2009) Use of 3'-deoxy-3'-[18F]fluorothymidine PET/CT for evaluating response to cytotoxic chemotherapy in dogs with non-Hodgkin's lymphoma. Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 50: 660-8|
|Vail DM, Thamm DH, Reiser H, et al. (2009) Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 3503-10|